Konferenzen zum Thema Immunologie und Allergie in Großbritannien

Wählen Sie ein Land aus
Superbugs & Superdrugs — SMi’s 22nd Annual Superbugs & Superdrugs Conference
30. Mär 2020 - 31. Mär 2020 • London, Großbritannien
SMi Group
As one of the most impactful pharmaceuticals for maintaining public health, antibiotics have been around since early 20th century and have since shown a need for significant progress in recent years. This is mainly due to its broad and indiscriminate use which has slowly given birth to multi- to extensively-drug resistant bacteria rendering our current last-resort antibiotic arsenal, including colistin, carbapenems, 3rd and 4th generation cephalosporins, useless. This year’s event aims to showcase a suite of sessions focused on novel drugs and approaches, particularly highlighting non-traditional and traditional therapies that provide an innovative means to spearhead the issue. The conference will also place significant emphasis on the much-needed support for innovative approaches such as sessions tackling the funding and support and the regulation that provides guidance towards the goal of ameliorating the continued rise of anti-microbial resistance AMR. It is crucial to bring industry leaders together to discuss the strategies in place that reduce AMR, evaluate the role pharmaceutical companies and funding bodies play in reducing AMR, learn about new diagnostics approaches to identify AMR and consider novel candidates and alternatives to anti-microbials. Join us in March 2020, along with leaders from the pharmaceutical industry, academia, regulatory and funding bodies, and public-private partnerships to discuss the way forward.
Tel.: [02078276000];     Email: events@smi-online.co.uk
Resistance; superbugs; superdrugs; mrsa; infectious diseases; investment; smart materials, infection, drug discovery, antibacterial, antimicrobial, anti-infective, multidrug resistance, MDR, diagnostics, immunization, inhibitors, antibiotic, resistance, antibiotic resistance, vaccine, bacterial, infections, drive a-b, genome sequencing, multi-resistant gram-negative, BARDA, Microbiota, EBOLA, bacteria, biotech, biomedical, pem, disease, amr, ppp, health, containment, microbiology, hepatitis, hcv, clinical, lab, gram positive, gram negative, fungi, fungal, population, contamination, viral, virus, amr, zika, fda, pathogen
5th Annual Advances in Immuno-Oncology Congress
21. Mai 2020 - 22. Mai 2020 • London, Großbritannien
Oxford Global Conferences
Immuno-Oncology, Cancer Immunology, Cancer Vaccines, Immunotherapy, Oncology Cell Therapy, Antibody Development, T-Cell Engineering, Immune Biology, Combination Therapy, CAR-T Cell Therapy, Checkpoint Inhibitors, Bispecific, Assay Development, Cancer Genetics/Genomics, Personalised Medicine, Biomarker, Translational Immunology, Preclinical Development, Clinical Oncology, Clinical Trial Management, Clinical Development
Verwandte Fachgebiete:

Conference-Service.com stellt der Öffentlichkeit ein Kalendarium wichtiger Konferenzen, Symposien und sonstiger Tagungen im wissenschaftlich-technischen Bereich zur Verfügung. Obwohl das Verzeichnis mit großer Sorgfalt zusammengestellt und ständig aktualisiert wird, weisen wir auf die Möglichkeit von Fehlern ausdrücklich hin. Bitte vergewissern Sie sich immer beim Veranstalter, bevor Sie über die Teilnahme oder Nichtteilnahme an einer Konferenz entscheiden.

Stand vom 15. November 2019